Ribociclib 200 mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 200 mg
Reference Brands: Kisqali (USA/EU)
Category: Oncology Cancer Care
Ribociclib is a cyclin‑dependent kinase (CDK 4/6) inhibitor. It works by blocking CDK 4 and CDK 6, proteins that help cancer cells grow and divide, thereby reducing or slowing the growth of certain breast cancer cells. Ribociclib is used together with hormonal therapies, such as aromatase inhibitors or fulvestrant, in hormone receptor‑positive (HR+), HER2‑negative breast cancer, whether early (high‑risk) or advanced/metastatic.
Ribociclib — third party manufacturing & bulk supply
Ribociclib 200 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Ribociclib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Ribociclib →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Ribociclib is used to treat hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer, typically in combination with endocrine therapy. It works by inhibiting cyclin-dependent kinases 4 and 6 (CDK4/6), which slows cancer cell growth.
Ribociclib is made from the active pharmaceutical ingredient ribociclib succinate, a selective CDK4/6 inhibitor.
The trade name is Kisqali.
Kisqali is manufactured by Novartis.
The generic name is ribociclib succinate.
The primary brand name is Kisqali.
It is manufactured in approved facilities in Europe, the USA, and other regions depending on regulatory approvals.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
